CYH Community Health Systems, Inc. Common Stock
NYSE · Health Care · Ver em SEC EDGAR ↗ fechar Out 2, 2026 10-K/10-Q Jul 23, 2026CYH Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
CYH Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
A granularidade da barra se adapta ao período selecionado — passe o mouse sobre o gráfico para ver a abertura/máxima/mínima/fechamento de uma barra.
| Data ex | Desdobramento | Tipo |
|---|---|---|
| 22 de Abril de 2016 | 121-for-100 | Para frente |
Sobre Community Health Systems, Inc. Common Stock Visão geral da empresa da Wikipedia
Community Health Systems, Inc. (CHS) is a Fortune 500 company based in Franklin, Tennessee. It was the largest provider of general hospital healthcare services in the United States in terms of number of acute care facilities. In 2014, CHS had around 200 hospitals, but the number had declined to around 85 in 2021.
In August 2015, the company announced plans to spin off 38 hospitals and its management and consulting subsidiary, Quorum Health Resources, into a new publicly traded company called Quorum Health Corporation. The company completed the spinoff of Quorum Health Corporation on April 29, 2016. Quorum owns or leases hospitals across 16 states, primarily in cities or counties with populations of 50,000 or less. In April 2020 Quorum declared bankruptcy and is no longer trading on the NYSE.
On October 3, 2016, CHS was removed from the S&P Midcap 400 and added to the S&P Smallcap 600. Under CEO Wayne T. Smith, the company's stock has lost over 76% of its value since the year 2000.
Chinese billionaire Tianqiao Chen had a 22.2 percent stake in Community Health Systems in 2017.
History
Founding and early years (1985–2014)
E. Thomas Chaney, former executive of Hospital Affiliates, Inc. and David Steffy and Richard Ragsdale, former executives at Hospital Corporation of America spinoff Republic Health Corporation, formed Community Health Systems in 1985.
The company made its initial public offering in 1991. In 1996, the company was purchased by private equity firm Forstmann Little & Company. Community Health Systems went public again in 2000. In August 2003, the company acquired Southside Regional Medical Center. On October 10, 2015, the 372-bed Grandview Medical Center began operating in Birmingham, Alabama, replacing Trinity Medical Center.
In 2000, Community Health Systems paid $31 million to the United States Department of Justice to settle a review of its billing practices.
In 2007, Community Health Systems purchased Plano, Texas-based Triad Hospitals for $6.8 billion, adding nearly 50 hospitals, hospital management and consulting business Quorum Health Resources, and nearly doubling the size of the company. Among the facilities included in the deal was McKenzie-Willamette Hospital in Springfield, Oregon; Trinity Medical Center in Birmingham, Alabama; and the seven hospitals of Lutheran Health Network in the Ft. Wayne, Indiana region.
In 2010, McKenzie-Willamette's healthcare workers' union, SEIU, Local 49, claimed that workload increases, slashed benefits, and staff reductions had lowered the quality of both patient care and quality of life for employees. The union, in its "Profits Before Community" campaign against the hospital, continues to highlight that profits have tripled while charitable care and employee benefits have steadily decreased since the hospital moved from a non-profit to a for-profit enterprise under CHS.
In 2011, it was accused by Tenet Healthcare of overbilling Medicare in its aggressive admissions policy compared to its peers. It was subpoenaed by Medicare on its aggressive billing to the Medicare systems.
In 2013, Community Health Systems entered into an agreement with Health Management Associates to purchase HMA for about $3.6 billion in cash and stock. The merger was completed in January 2014 and made Community Health Systems the largest for-profit hospital operator at the time, with 206 hospitals in 29 states. The acquisition of HMA brought with it liability for lawsuits and criminal charges of fraudulent claims against Medicare and other federal programs. CHS settled these claims for $262 million in October, 2018.
On August 4, 2014, Community Health Systems paid $95.14 million to the United States Department of Justice to resolve multiple lawsuits "alleging that the company knowingly billed government health care programs for inpatient services that should have been billed as outpatient or observation services". As part of the agreement, Community Health Systems was required to enter into a corporate integrity agreement that required the company to participate in compliance efforts.
It was reported on August 18, 2014, that hackers broke into Community Health System's records system and stole data on 4.5 million patients. These data included names, Social Security numbers, physical addresses, birthdays and telephone numbers. CHS provided all patients whose records were impacted with free identity theft protection.
Recent developments (2015–present)
On February 2, 2015, Community Health Systems was required to pay $75 million to settle allegations "that they made illegal donations to county governments to reap more federal dollars under a now-discontinued matching program". The allegations were brought about by a former CHS employee in a complaint under the False Claims Act.
In October 2015, Community Health Systems paid $13 million to the United States Department of Justice to resolve allegations related to the False Claims Act.
After CHS agreed in 2015 to sell Memorial Hospital of Salem County in New Jersey to Prime Healthcare Foundation, a nonprofit affiliated with Prime Healthcare Services; the sale was approved by New Jersey in early February 2017.
On December 6, 2016, a former CFO of a CHS hospital was awarded $1.9 million in a whistleblower lawsuit he filed after he was terminated for refusing to submit false financial documents.
In January 2017, a settlement between investors and CHS executives for $60 million was reached. The settlement resolved allegations of "breach of fiduciary duty" by CHS executives.
In March 2017, Quorum's board retained outside counsel in relation to whether Community Health Systems had committed fraud with regards to financial projections for Quorum, and whether any of its current management may have been involved in any possible fraud. In June 2017 Quorum said although the investigation did not produce "conclusive evidence" of fraud the projections appeared to be incompetent at best.
In April–July 2017, Community Health Systems rejected overtures from key Lutheran Health Network doctors to facilitate sale of its profitable network in CHS to a third party, after assertions of continual lack of re-investment into the network's facilities and staff by CHS management. After those discussions/accusations became public, several key leaders of the affiliated hospitals, Lutheran and Dupont, and the network were fired or resigned. Key prominent local community leaders Chuck Surack and Tom Kelley resigned from the Lutheran Health Network's and hospitals' advisory boards.
On March 13, 2018, it was reported that the company had hired financial advisory firm Lazard to help address long-term debt.
On August 1, 2018, CHS completed the sale of 425-bed Munroe Regional Medical Center in Ocala, Fla., to Altamonte Springs, Fla.-based Adventist Health System.
On May 22, 2019, AdventHealth announced they had signed definitive agreements to purchase 193-bed Heart of Florida Regional Medical Center in Davenport, Florida, and 160-bed Lake Wales Medical Center in Lake Wales, Florida, from affiliates of CHS.
In December 2019, CHS announced that subsidiaries of the company have completed the sale of three Virginia hospitals – Southside Regional Medical Center in Petersburg, Southampton Memorial Hospital in Franklin, and Southern Virginia Regional Medical Center in Emporia, effective on January 1, 2020.
On April 27, 2020, CHS announced that an affiliate of the company has signed a definitive agreement to sell its majority ownership interest in 84‑bed St. Cloud Regional Medical Center and its associated healthcare operations in St. Cloud, Florida, to a subsidiary of Orlando Health. Orlando Health currently holds minority ownership interest in St. Cloud and will purchase the remaining interest through this transaction.
On September 30, 2020, CHS announced that an affiliate of the company has completed the sale of 480-bed Bayfront Health St. Petersburg and its associated assets to a subsidiary of Orlando Health.
In its annual Form 10-K filed in 2019, it identified Florida, Texas and Indiana as areas of geographic concentration.
In 2014, CHS had around 200 hospitals, but the number had declined to around 85 in 2021.
From March 2020 to May 2021, during the COVID-19 pandemic, CHS filed more than 19,000 lawsuits against individuals for not being able to pay off their medical debt (some from hospitals it no longer owned) even as the company collected over $700 million in Covid relief funds from the federal government. Many of these lawsuits were against people who could not pay the legal fees to challenge CHS in court. (Due to the fact that these are civil suits and not criminal suits, the defendants do not receive a state-appointed lawyer.) In 2020, CHS posted its most profitable year in at least a decade.
Predatory liens practices
Lawsuits have been filed against CHS hospitals for alleged predatory liens practices where hospitals file for liens rather than bill individuals' health insurers, resulting in massive fees for patients.
Fonte: Wikipedia (Inglês), CC BY-SA 4.0 · Ver na Wikipedia ↗
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
| Métrica | Tendência de 5 anos | CYH | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| P/E (TTM) | 1.5média 5A ≈3.4 | ≈3.4 | 15.5 | Subvalorizado | |
| P/S (TTM) | 0.0média 5A ≈0.1 | ≈0.1 | 1.2 | Subvalorizado | |
| P/B (MRQ) | -0.3média 5A ≈-0.5 | ≈-0.5 | · | · | |
| EV / EBITDA | 7.1média 5A ≈13.1 | ≈13.1 | 10.6 | Subvalorizado | |
| Preço / FCF (TTM) | -2.1média 5A ≈-0.8 | ≈-0.8 | · | · | |
| Preço / Fluxo de Caixa (TTM) | 3.0média 5A ≈-1.6 | ≈-1.6 | 6.5 | Subvalorizado | |
| EV / Revenue (EV / Receita) | 0.8média 5A ≈1.0 | ≈1.0 | · | · | |
| EV / FCF | 50.5média 5A ≈-4.9 | ≈-4.9 | · | · |
A mediana dos pares é calculada em uma base padronizada por métrica e pode não corresponder sempre à base TTM/MRQ mostrada para esta ação.
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
| Métrica | Tendência de 5 anos | CYH | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Margem Operacional (TTM) | 11.4%média 5A ≈8.4% | ≈8.4% | 13.8% | Em linha | |
| EBITDA Margin (Margem EBITDA) | 11.9%média 5A ≈8.4% | ≈8.4% | 10.2% | Primeira linha | |
| Margem de Impostos Pré-Tributação (TTM) | 3.9%média 5A ≈2.4% | ≈2.4% | 6.4% | Em linha | |
| Margem de Lucro Líquido (TTM) | 2.1%média 5A ≈0.24% | ≈0.24% | 4.3% | Fraco | |
| ROA (TTM) | 2.0%média 5A ≈0.20% | ≈0.20% | 3.7% | Em linha | |
| ROE (TTM) | -16.7%média 5A ≈-1.7% | ≈-1.7% | 8.2% | Fraco | |
| ROIC | 15.5%média 5A ≈7.4% | ≈7.4% | 10.2% | Primeira linha |
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
| Métrica | Tendência de 5 anos | CYH | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Dívida / Patrimônio Líquido (MRQ) | -6.9média 5A ≈-7.8 | ≈-7.8 | 0.3 | Baixa dívida | |
| Índice de liquidez corrente (MRQ) | 1.5média 5A ≈1.5 | ≈1.5 | 1.5 | Em linha | |
| Quick Ratio (Índice de Liquidez Seca) | 1.1média 5A ≈1.0 | ≈1.0 | 1.0 | Em linha | |
| Dívida de Longo Prazo / Patrimônio Líquido (MRQ) | -6.9média 5A ≈-7.8 | ≈-7.8 | 0.3 | Baixa dívida |
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
| Métrica | Tendência de 5 anos | CYH | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Revenue YoY (Receita Ano a Ano) | -1.2%média 5A ≈1.2% | ≈1.2% | · | · | |
| Revenue CAGR 3Y (CAGR Receita 3A) | 0.74%média 5A ≈1.1% | ≈1.1% | · | · | |
| Revenue CAGR 5Y (CAGR Receita 5A) | 1.1% | · | · | · | |
| EPS CAGR 3Y (CAGR de LPA 3A) | 120.8% | · | · | · | |
| EPS CAGR 5Y (CAGR de LPA 5A) | -3.0% | · | · | · | |
| Net Income CAGR 3Y (CAGR de Lucro Líquido 3A) | 122.8% | · | · | · | |
| Net Income CAGR 5Y (CAGR de Lucro Líquido 5A) | -0.08% | · | · | · |
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
| Métrica | Tendência de 5 anos | CYH | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Asset Turnover (Giro do Ativo) | 0.9média 5A ≈0.9 | ≈0.9 | 0.9 | Em linha | |
| Receivables Turnover (Giro de Contas a Receber) | 5.7média 5A ≈5.9 | ≈5.9 | 8.9 | Fraco | |
| Revenue / Employee (Receita anual ÷ funcionários (número de funcionários reportado, yfinance). Derivado — não é um conceito SEC-XBRL armazenado.) | ≈$283.8K | · | · | · |
valor · ≈ média 5A · mediana do setor · veredicto relativo à mediana
Dividendos Rendimento, índice de pagamento, histórico de dividendos, CAGR de 5 anos
| Data ex | Valor | Moeda | Rendimento |
|---|---|---|---|
| Dez 13, 2012 | $0,21 | USD | ≈0.84% |
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
| Período | Relatório | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|---|
| 30 de Junho de 2026 | Jul 21, 2026 | $-0.19 | $-0.06 | -201.1% |
| 31 de Março de 2026 | $-0.48 | $-0.10 | -387.3% | |
| 31 de Dezembro de 2025 | $-0.01 | $-0.10 | 90.5% | |
| 30 de Setembro de 2025 | $1.27 | $-0.25 | 610.5% | |
| 30 de Junho de 2025 | $-0.05 | $-0.11 | 52.6% | |
| 31 de Março de 2025 | $-0.03 | $-0.08 | 62.6% |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $12.48B | $12.63B | $12.49B | $12.21B | $12.37B | $11.79B | $13.21B | $14.15B | $15.35B | $18.44B | |
| Cost of Revenue | $1.86B | $1.95B | $1.99B | $1.98B | $2.04B | $1.96B | $2.15B | $2.35B | $2.67B | $3.01B | |
| Operating Expenses | $11.00B | $12.09B | $11.53B | $11.39B | $10.97B | $10.66B | $12.56B | $13.95B | $17.23B | $19.30B | |
| Operating Income | $1.49B | $542M | $957M | $821M | $1.40B | $1.13B | $650M | $208M | $-1.88B | $-860M | |
| Interest Income | $2M | $3M | $2M | $2M | $3M | $3M | $3M | $7M | $11M | $14M | |
| Pretax Income | $724M | $-283M | $207M | $349M | $499M | $422M | $-430M | $-715M | $-2.83B | $-1.72B | |
| Income Tax | $48M | $79M | $191M | $170M | $131M | $-185M | $160M | $-11M | $-449M | $-104M | |
| Net Income | $509M | $-516M | $-133M | $46M | $230M | $511M | $-675M | $-788M | $-2.46B | $-1.72B | |
| EPS (Basic) | $3.81 | $-3.90 | $-1.02 | $0.35 | $1.82 | $4.43 | $-5.93 | $-6.99 | $-22.00 | $-15.54 | |
| EPS (Diluted) | $3.77 | $-3.90 | $-1.02 | $0.35 | $1.76 | $4.39 | $-5.93 | $-6.99 | $-22.00 | $-15.54 | |
| Shares (Basic) | 133,564,227 | 132,101,768 | 130,445,677 | 128,808,387 | 126,754,852 | 115,491,022 | 113,739,046 | 112,728,274 | 111,769,821 | 110,730,971 | |
| Shares (Diluted) | 135,012,240 | 132,101,768 | 130,445,677 | 130,060,319 | 130,597,410 | 116,544,561 | 113,739,046 | 112,728,274 | 111,769,821 | 110,730,971 | |
| EBITDA | $1.49B | $542M | $957M | $821M | $1.40B | $1.13B | $1.26B | $908M | $-1.02B | $240M |
Balanço Patrimonial
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $260M | $37M | $38M | $118M | $507M | $1.68B | $216M | $196M | $563M | $238M | |
| Receivables | $2.08B | $2.29B | $2.23B | $2.04B | $2.06B | $1.93B | $2.26B | $2.35B | $2.38B | $3.18B | |
| Other Current Assets | $381M | $358M | $275M | $235M | $269M | $338M | $358M | $400M | $462M | $568M | |
| Current Assets | $3.23B | $3.30B | $3.21B | $3.08B | $3.48B | $4.51B | $3.43B | $3.55B | $4.07B | $4.67B | |
| PP&E (Net) | $4.50B | $4.78B | $5.21B | $5.37B | $5.55B | $5.32B | $5.61B | $6.14B | $7.05B | $8.15B | |
| PP&E (Gross) | $8.91B | $9.16B | $9.51B | $9.64B | $9.76B | $9.35B | $9.65B | $10.30B | $11.50B | $12.42B | |
| Accum. Depreciation | $4.41B | $4.38B | $4.30B | $4.27B | $4.20B | $4.03B | $4.04B | $4.16B | $4.45B | $4.27B | |
| Goodwill | $3.32B | $3.79B | $3.96B | $4.17B | $4.22B | $4.22B | $4.33B | $4.56B | $4.72B | $6.52B | |
| Intangibles | $7M | $15M | $20M | $2M | · | · | · | · | $10M | $14M | |
| Other Non-current Assets | $2.10B | $2.17B | $2.05B | $2.01B | $1.91B | $1.90B | $2.21B | $1.54B | $1.54B | $2.59B | |
| Total Assets | $13.20B | $14.05B | $14.46B | $14.67B | $15.22B | $16.01B | $15.61B | $15.86B | $17.45B | $21.94B | |
| Accounts Payable | $842M | $913M | $912M | $773M | $830M | $783M | $811M | $887M | $967M | $995M | |
| Accrued Liabilities | · | · | · | · | · | · | $1.13B | $1.09B | $1.13B | $1.23B | |
| Current Liabilities | $2.21B | $2.35B | $2.14B | $2.19B | $2.36B | $2.81B | $2.28B | $2.39B | $2.36B | $2.89B | |
| Capital Leases | $537M | $535M | $563M | $605M | $535M | $524M | $487M | $84M | $287M | $302M | |
| Deferred Tax | $25M | $231M | $369M | $354M | $192M | $29M | $200M | $26M | $19M | $411M | |
| Other Non-current Liabilities | $891M | $828M | $739M | $644M | $827M | $1.60B | $894M | $1.01B | $1.36B | $1.57B | |
| Total Liabilities | $14.04B | $15.37B | $15.28B | $15.40B | $16.03B | $17.06B | $17.25B | $16.82B | $17.61B | $19.66B | |
| Long-term Debt | $10.40B | $11.45B | $11.49B | $11.63B | $12.14B | $12.22B | $13.40B | $13.60B | $13.91B | $15.24B | |
| Total Debt | $10.38B | $11.43B | $11.47B | $11.61B | $12.11B | $12.09B | $13.38B | · | · | · | |
| Common Stock | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Retained Earnings | $-3.57B | $-4.08B | $-3.56B | $-3.43B | $-3.48B | $-3.71B | $-4.22B | $-3.54B | $-2.76B | $-299M | |
| AOCI | $-9M | $-10M | $-14M | $-21M | $-14M | $-13M | $-9M | $-10M | $-21M | $-62M | |
| Stockholders' Equity | $-1.39B | $-1.91B | $-1.39B | $-1.37B | $-1.37B | $-1.62B | $-2.22B | $-1.53B | $-767M | $1.61B | |
| Liabilities + Equity | $13.20B | $14.05B | $14.46B | $14.67B | $15.22B | $16.01B | $15.61B | $15.86B | $17.45B | $21.94B | |
| Shares Outstanding | 138,626,917 | 138,919,641 | 136,774,911 | 134,703,717 | 132,146,282 | 129,612,117 | 117,822,631 | 116,248,376 | 114,651,004 | 113,876,580 |
Fluxo de Caixa
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $426M | $486M | $505M | $534M | $540M | $558M | $608M | $700M | $861M | $1.10B | |
| Stock-based Comp | $11M | $17M | $22M | $20M | $25M | $13M | $10M | $13M | $24M | $46M | |
| Deferred Tax | $-243M | $-116M | $35M | $165M | $171M | $-187M | $203M | $-3M | $-454M | $-116M | |
| Restructuring | · | · | · | · | $3M | · | · | · | · | · | |
| Other Non-cash | · | · | · | · | · | · | $239M | $352M | $2.80B | $1.83B | |
| Operating Cash Flow | $543M | $480M | $210M | $300M | $-131M | $2.18B | $385M | $274M | $773M | $1.14B | |
| CapEx | $335M | $360M | $467M | $415M | $469M | $440M | $438M | $527M | $564M | $744M | |
| Investing Cash Flow | $847M | $-275M | $-26M | $-259M | $-524M | $177M | $-2M | $-245M | $1.07B | $630M | |
| Net Debt Issued | $-6.52B | $-5.06B | $-4.32B | $-2.36B | $-4.43B | $-5.49B | $-3.56B | $-2.03B | $-5.39B | $-6.71B | |
| Financing Cash Flow | $-1.17B | $-206M | $-264M | $-430M | $-514M | $-895M | $-363M | $-396M | $-1.52B | $-1.71B | |
| Net Change in Cash | $223M | $-1M | $-80M | $-389M | $-1.17B | $1.46B | $20M | $-367M | $325M | $54M | |
| Taxes Paid | $249M | $171M | $91M | $-6M | $-4M | $-2M | $3M | $19M | $-4M | $16M | |
| Free Cash Flow | $208M | $120M | $-257M | $-115M | $-600M | $1.74B | $-53M | $-253M | $209M | $393M |
Lucratividade
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 11.9% | 4.3% | 7.7% | 6.7% | 11.3% | 9.6% | 4.9% | 1.5% | · | · | |
| Net Margin | 4.1% | -4.1% | -1.1% | 0.38% | 1.9% | 4.3% | -5.1% | -5.6% | · | · | |
| Pretax Margin | 5.8% | -2.2% | 1.7% | 2.9% | 4.0% | 3.6% | -3.3% | -5.1% | · | · | |
| EBITDA Margin | 11.9% | 4.3% | 7.7% | 6.7% | 11.3% | 9.6% | 9.5% | 6.4% | · | · | |
| ROA | 3.7% | -3.6% | -0.91% | 0.31% | 1.5% | 3.2% | -4.3% | -4.7% | -12.5% | -7.1% | |
| ROE | -30.8% | 31.2% | 9.6% | -3.4% | -15.3% | -26.6% | 36.0% | 68.5% | -580.0% | -61.1% | |
| ROIC | 15.5% | 7.3% | 0.73% | 4.1% | 9.6% | 15.5% | 8.0% | -13.3% | 206.0% | -50.0% |
Liquidez e Solvência
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | 1.4 | 1.5 | 1.4 | 1.5 | 1.6 | 1.5 | 1.5 | 1.7 | 1.6 | |
| Quick Ratio | 1.1 | 1.0 | 1.1 | 1.0 | 1.1 | 1.3 | 1.1 | 1.1 | 1.3 | 1.2 | |
| Debt / Equity | -7.4 | -6.0 | -8.2 | -8.5 | -8.8 | -7.4 | -6.0 | · | · | · | |
| LT Debt / Equity | -7.4 | -6.0 | -8.2 | -8.5 | -8.8 | -7.4 | -6.0 | · | · | · |
Eficiência
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.9 | 0.9 | 0.9 | 0.8 | 0.8 | 0.7 | 0.8 | 0.8 | · | · | |
| Receivables Turnover | 5.7 | 5.6 | 5.8 | 6.0 | 6.2 | 5.6 | 5.7 | 6.0 | · | · |
Por Ação
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-10.06 | $-13.78 | $-10.18 | $-10.15 | $-10.38 | $-12.54 | $-18.82 | $-13.20 | $-6.69 | $14.18 | |
| Revenue / Share | $92.47 | $95.64 | $95.75 | $93.89 | $94.70 | $101.15 | $116.14 | $125.57 | · | · | |
| Cash Flow / Share | $4.02 | $3.63 | $1.61 | $2.31 | $-1.00 | $18.69 | $3.38 | $2.43 | $6.92 | $10.27 | |
| Cash / Share | $1.88 | $0.27 | $0.28 | $0.88 | $3.84 | $12.93 | $1.83 | $1.69 | $4.91 | $2.09 | |
| EPS (TTM) | $3.77 | $-3.90 | $-1.02 | $0.35 | $1.76 | $4.39 | $-5.93 | $-6.99 | $-22.00 | $-15.54 |
Taxas de Crescimento
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -1.2% | 1.1% | 2.3% | -1.3% | 4.9% | · | · | · | · | · | |
| Revenue CAGR 3Y | 0.74% | 0.71% | 1.9% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 1.1% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | · | · | -80.1% | -59.9% | · | · | · | · | · | |
| EPS CAGR 3Y | 120.8% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -3.0% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | · | · | -80.0% | -55.0% | · | · | · | · | · | |
| Net Income CAGR 3Y | 122.8% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -0.08% | · | · | · | · | · | · | · | · | · |
Avaliação (TTM)
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $12.48B | $12.63B | $12.49B | $12.21B | $12.37B | $11.79B | $13.21B | $14.15B | $15.35B | $18.44B | |
| Net Income TTM | $509M | $-516M | $-133M | $46M | $230M | $511M | $-675M | $-788M | $-2.46B | $-1.72B | |
| Market Cap | $433M | $415M | $428M | $582M | $1.76B | $963M | $342M | $328M | $488M | $637M | |
| Enterprise Value | $10.55B | $11.81B | $11.86B | $12.08B | $13.36B | $11.38B | $13.51B | · | · | · | |
| P/E | 0.8 | -0.8 | -3.1 | 12.3 | 7.6 | 1.7 | -0.5 | -0.4 | -0.2 | -0.4 | |
| P/S | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | |
| P/B | -0.3 | -0.2 | -0.3 | -0.4 | -1.3 | -0.6 | -0.2 | -0.2 | -0.6 | 0.4 | |
| P / Cash Flow | 0.8 | 0.9 | 2.0 | 1.9 | -13.4 | 0.4 | 0.9 | 1.2 | 0.6 | 0.6 | |
| P / FCF | 2.1 | 3.5 | -1.7 | -5.1 | -2.9 | 0.6 | -6.4 | -1.3 | 2.3 | 1.6 | |
| EV / EBITDA | 7.1 | 21.8 | 12.4 | 14.7 | 9.5 | 10.1 | 10.7 | · | · | · | |
| EV / FCF | 50.7 | 98.4 | -46.1 | -105.0 | -22.3 | 6.5 | -254.9 | · | · | · | |
| EV / Revenue | 0.8 | 0.9 | 0.9 | 1.0 | 1.1 | 1.0 | 1.0 | · | · | · | |
| Earnings Yield | 120.8% | -130.4% | -32.6% | 8.1% | 13.2% | 59.1% | -204.5% | -247.9% | -516.4% | -278.0% |
Demonstração de Resultados
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.83B | $2.96B | $3.11B | $3.09B | $3.13B | $3.16B | $3.26B | $3.09B | $3.14B | $3.14B | $3.18B | $3.09B | $3.12B | $3.11B | $3.14B | $3.02B | |
| Cost of Revenue | $401M | $441M | $446M | $460M | $469M | $489M | $507M | $469M | $483M | $487M | $493M | $489M | $504M | $507M | $497M | $492M | |
| Operating Expenses | $2.44B | $2.68B | $2.66B | $2.84B | $2.62B | $2.88B | $2.99B | $3.29B | $2.90B | $2.91B | $2.85B | $2.91B | $2.87B | $2.90B | $2.91B | $2.82B | |
| Operating Income | $389M | $281M | $449M | $243M | $512M | $284M | $278M | $-205M | $238M | $231M | $328M | $173M | $246M | $210M | $228M | $204M | |
| Interest Income | $1M | $1M | $0 | $1M | $1M | · | $1M | $1M | · | · | · | · | · | · | · | · | |
| Pretax Income | $180M | $64M | $221M | $-2M | $438M | $67M | $64M | $-419M | $50M | $22M | $194M | $-33M | $40M | $6M | $324M | $70M | |
| Income Tax | $76M | $89M | $61M | $-173M | $118M | $42M | $91M | $-64M | $24M | $28M | $108M | $19M | $38M | $26M | $-123M | $70M | |
| Net Income | $70M | $-58M | $110M | $130M | $282M | $-13M | $-71M | $-391M | $-13M | $-41M | $47M | $-91M | $-38M | $-51M | $415M | $-42M | |
| EPS (Basic) | $0.51 | $-0.43 | $0.83 | $0.97 | $2.11 | $-0.10 | $-0.53 | $-2.95 | $-0.10 | $-0.32 | $0.36 | $-0.69 | $-0.29 | $-0.40 | $3.20 | $-0.32 | |
| EPS (Diluted) | $0.51 | $-0.43 | $0.82 | $0.96 | $2.09 | $-0.10 | $-0.53 | $-2.95 | $-0.10 | $-0.32 | $0.36 | $-0.69 | $-0.29 | $-0.40 | $3.20 | $-0.32 | |
| Shares (Basic) | 135,494,789 | 134,417,158 | · | 133,787,535 | 133,763,733 | 132,876,691 | · | 132,376,226 | 132,344,504 | 131,272,044 | · | 130,698,907 | 130,659,672 | 129,688,917 | · | 129,141,673 | |
| Shares (Diluted) | 136,505,102 | 134,417,158 | · | 135,187,592 | 134,882,981 | 132,876,691 | · | 132,376,226 | 132,344,504 | 131,272,044 | · | 130,698,907 | 130,659,672 | 129,688,917 | · | 129,141,673 | |
| EBITDA | $389M | $281M | · | $243M | $512M | $284M | · | $-205M | $238M | $231M | · | $173M | $246M | $210M | · | $204M |
Balanço Patrimonial
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $149M | $712M | $260M | $123M | $456M | $431M | $37M | $33M | $39M | $48M | · | $91M | $118M | $144M | · | $300M | |
| Receivables | $2.14B | $2.14B | $2.08B | $2.16B | $2.26B | $2.33B | $2.29B | $2.04B | $2.19B | $2.19B | · | $2.16B | $2.04B | $2.04B | · | $1.97B | |
| Other Current Assets | $308M | $421M | $381M | $325M | $351M | $61M | $358M | $402M | $292M | $307M | · | $325M | $339M | $227M | · | $301M | |
| Current Assets | $3.08B | $3.77B | $3.23B | $3.20B | $3.66B | $3.41B | $3.30B | $3.11B | $3.20B | $3.17B | · | $3.25B | $3.19B | $3.11B | · | $3.27B | |
| PP&E (Net) | $4.18B | $4.20B | $4.50B | $4.62B | $4.66B | $4.74B | $4.78B | $4.96B | $5.22B | $5.22B | · | $5.16B | $5.25B | $5.25B | · | $5.45B | |
| PP&E (Gross) | $8.04B | $8.09B | $8.91B | $9.06B | $9.02B | $9.20B | $9.16B | $9.09B | $9.59B | $9.61B | · | $9.37B | $9.53B | $9.56B | · | $9.73B | |
| Accum. Depreciation | $3.86B | $3.89B | $4.41B | $4.44B | $4.37B | $4.46B | $4.38B | $4.13B | $4.37B | $4.39B | · | $4.21B | $4.28B | $4.30B | · | $4.28B | |
| Goodwill | $3.23B | $3.13B | $3.32B | $3.54B | $3.60B | $3.79B | $3.79B | $3.94B | $3.97B | $3.96B | $3.96B | $3.94B | $4.05B | $4.05B | $4.17B | $4.20B | |
| Intangibles | · | · | $7M | · | · | · | $15M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $1.65B | $2.05B | $2.10B | $1.81B | $1.71B | $1.94B | $2.17B | $1.86B | $1.99B | $2.04B | · | $2.27B | $2.10B | $2.15B | · | $1.94B | |
| Total Assets | $12.18B | $13.18B | $13.20B | $13.24B | $13.64B | $13.89B | $14.05B | $13.90B | $14.41B | $14.42B | · | $14.67B | $14.65B | $14.62B | · | $14.91B | |
| Accounts Payable | $713M | $790M | $842M | $894M | $970M | $974M | $913M | $842M | $896M | $941M | · | $837M | $736M | $712M | · | $820M | |
| Current Liabilities | $2.02B | $2.57B | $2.21B | $2.18B | $2.29B | $2.37B | $2.35B | $2.13B | $2.17B | $2.14B | · | $2.15B | $2.08B | $2.13B | · | $2.38B | |
| Capital Leases | $527M | $504M | $537M | $527M | $514M | $535M | $535M | $528M | $542M | $546M | · | $560M | $580M | $588M | · | $563M | |
| Deferred Tax | $25M | $25M | $25M | $30M | $240M | $205M | $231M | $239M | $351M | $354M | · | $344M | $362M | $351M | · | $477M | |
| Other Non-current Liabilities | $901M | $922M | $891M | $866M | $850M | $806M | $828M | $815M | $721M | $726M | · | $694M | $722M | $647M | · | $726M | |
| Total Liabilities | $13.02B | $14.14B | $14.04B | $14.19B | $14.74B | $15.22B | $15.37B | $15.18B | $15.29B | $15.29B | · | $15.57B | $15.47B | $15.41B | · | $16.09B | |
| Long-term Debt | · | · | $10.40B | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Debt | $9.55B | $10.13B | · | $10.59B | $10.84B | $11.30B | · | $11.47B | $11.50B | $11.53B | · | $11.82B | $11.73B | $11.70B | · | $11.94B | |
| Common Stock | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | · | $1M | $1M | $1M | · | $1M | |
| Retained Earnings | $-3.56B | $-3.63B | $-3.57B | $-3.68B | $-3.81B | $-4.09B | $-4.08B | $-4.01B | $-3.62B | $-3.60B | · | $-3.61B | $-3.52B | $-3.48B | · | $-3.85B | |
| AOCI | $-11M | $-10M | $-9M | $-5M | $-5M | $-7M | $-10M | $-8M | $-13M | $-16M | · | $-23M | $-19M | $-18M | $-21M | $-33M | |
| Stockholders' Equity | $-1.39B | $-1.45B | $-1.39B | $-1.50B | $-1.63B | $-1.92B | $-1.91B | $-1.82B | $-1.44B | $-1.43B | · | $-1.46B | $-1.49B | $-1.45B | · | $-1.79B | |
| Liabilities + Equity | $12.18B | $13.18B | $13.20B | $13.24B | $13.64B | $13.89B | $14.05B | $13.90B | $14.41B | $14.42B | · | $14.67B | $14.65B | $14.62B | · | $14.91B | |
| Shares Outstanding | 141,010,284 | 140,916,712 | 138,626,917 | 140,119,616 | 140,119,616 | 140,302,924 | 138,919,641 | 138,936,058 | 138,960,194 | 138,966,388 | · | 136,772,094 | 136,802,806 | 136,749,427 | · | 134,698,067 |
Fluxo de Caixa
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $108M | $114M | $108M | $108M | $105M | $105M | $129M | $117M | $125M | $115M | $121M | $128M | $124M | $132M | $136M | $137M | |
| Stock-based Comp | $2M | $3M | $5M | $-1M | $3M | $4M | $5M | $4M | $2M | $6M | $6M | $6M | $4M | $6M | $6M | $6M | |
| Operating Cash Flow | $88M | $-297M | $266M | $69M | $88M | $120M | $216M | $67M | $101M | $96M | $90M | $29M | $86M | $5M | $9M | $137M | |
| CapEx | $76M | $76M | $94M | $65M | $91M | $85M | $109M | $70M | $88M | $93M | $110M | $130M | $105M | $122M | $131M | $93M | |
| Investing Cash Flow | $-23M | $1.02B | $142M | $-81M | $342M | $444M | $-143M | $75M | $-108M | $-99M | $180M | $-101M | $-86M | $-19M | $-52M | $30M | |
| Net Debt Issued | · | $-351M | · | · | · | $-1.09B | · | · | · | $-885M | · | · | · | $-757M | · | · | |
| Financing Cash Flow | $-628M | $-274M | $-271M | $-321M | $-405M | $-170M | $-69M | $-148M | $-2M | $13M | $-323M | $45M | $-26M | $40M | $-139M | $-213M | |
| Net Change in Cash | $-563M | $452M | $137M | $-333M | $25M | $394M | $4M | $-6M | $-9M | $10M | $-53M | · | · | $26M | $-182M | $-46M | |
| Taxes Paid | $61M | $0 | $441M | $-91M | $181M | $80M | $303M | $-48M | $-84M | $0 | $152M | $-24M | $-37M | · | $0 | $0 | |
| Free Cash Flow | · | $-373M | · | · | · | $35M | · | · | · | $3M | · | · | · | $-117M | · | · |
Lucratividade
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 13.8% | 9.5% | · | 7.9% | 16.3% | 9.0% | · | -6.6% | 7.6% | 7.4% | · | 5.6% | 7.9% | 6.8% | · | 6.7% | |
| Net Margin | 2.5% | -2.0% | · | 4.2% | 9.0% | -0.41% | · | -12.7% | -0.41% | -1.3% | · | -2.9% | -1.2% | -1.6% | · | -1.4% | |
| Pretax Margin | 6.4% | 2.2% | · | -0.06% | 14.0% | 2.1% | · | -13.6% | 1.6% | 0.70% | · | -1.1% | 1.3% | 0.19% | · | 2.3% | |
| EBITDA Margin | 13.8% | 9.5% | · | 7.9% | 16.3% | 9.0% | · | -6.6% | 7.6% | 7.4% | · | 5.6% | 7.9% | 6.8% | · | 6.7% | |
| ROA | 0.54% | -0.43% | · | 0.96% | 2.0% | -0.09% | · | -2.7% | -0.09% | -0.28% | · | -0.62% | -0.26% | -0.34% | · | -0.27% | |
| ROE | -4.6% | 3.4% | · | -7.8% | -18.4% | 0.78% | · | 23.8% | 0.89% | 2.9% | · | 5.6% | 2.4% | 3.6% | · | 2.5% | |
| ROIC | 2.8% | -1.3% | · | -228.6% | 4.1% | 1.1% | · | -1.8% | 1.2% | -0.62% | · | 2.6% | 0.12% | -6.8% | · | 0.00% |
Liquidez e Solvência
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | 1.5 | · | 1.5 | 1.6 | 1.4 | · | 1.5 | 1.5 | 1.5 | · | 1.5 | 1.5 | 1.5 | · | 1.4 | |
| Quick Ratio | 1.1 | 1.1 | · | 1.0 | 1.2 | 1.2 | · | 1.0 | 1.0 | 1.0 | · | 1.0 | 1.0 | 1.0 | · | 1.0 | |
| Debt / Equity | -6.9 | -7.0 | · | -7.0 | -6.6 | -5.9 | · | -6.3 | -8.0 | -8.1 | · | -8.1 | -7.9 | -8.1 | · | -6.7 | |
| LT Debt / Equity | -6.9 | -7.0 | · | -7.0 | -6.6 | -5.9 | · | -6.3 | -8.0 | -8.1 | · | -8.1 | -7.9 | -8.1 | · | -6.7 |
Eficiência
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Receivables Turnover | 1.3 | 1.3 | · | 1.5 | 1.4 | 1.4 | · | 1.5 | 1.5 | 1.5 | · | 1.5 | 1.5 | 1.5 | · | 1.5 |
Por Ação
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-9.86 | $-10.32 | · | $-10.72 | $-11.64 | $-13.71 | · | $-13.12 | $-10.37 | $-10.28 | · | $-10.70 | $-10.88 | $-10.57 | · | $-13.26 | |
| Revenue / Share | $20.70 | $22.06 | · | $22.83 | $23.23 | $23.77 | · | $23.34 | $23.73 | $23.92 | · | $23.61 | $23.84 | $23.96 | · | $23.42 | |
| Cash Flow / Share | · | $-2.21 | · | · | · | $0.90 | · | · | · | $0.73 | · | · | · | $0.04 | · | · | |
| Cash / Share | $1.06 | $5.05 | · | $0.88 | $3.25 | $3.07 | · | $0.24 | $0.28 | $0.35 | · | $0.67 | $0.86 | $1.05 | · | $2.23 | |
| EPS (TTM) | $1.86 | $3.44 | · | $2.42 | $-1.49 | $-3.68 | · | $-3.01 | $-0.75 | $-0.94 | · | $1.82 | $2.19 | $-0.04 | · | $-1.47 |
Avaliação (TTM)
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $11.98B | $12.29B | · | $12.64B | $12.65B | $12.65B | · | $12.55B | $12.55B | $12.52B | · | $12.45B | $12.39B | $12.21B | · | $12.30B | |
| Net Income TTM | $252M | $464M | · | $328M | $-193M | $-488M | · | $-398M | $-98M | $-123M | · | $235M | $284M | $-4M | · | $-192M | |
| Market Cap | $471M | $414M | · | $450M | $476M | $379M | · | $843M | $467M | $486M | · | $397M | $602M | $670M | · | $290M | |
| Enterprise Value | $9.87B | $9.83B | · | $10.92B | $10.86B | $11.25B | · | $12.28B | $11.93B | $11.97B | · | $12.13B | $12.21B | $12.22B | · | $11.93B | |
| P/E | 1.8 | 0.9 | · | 1.3 | -2.3 | -0.7 | · | -2.0 | -4.5 | -3.7 | · | 1.6 | 2.0 | -122.5 | · | -1.5 | |
| P/S | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.1 | · | 0.0 | |
| P/B | -0.3 | -0.3 | · | -0.3 | -0.3 | -0.2 | · | -0.5 | -0.3 | -0.3 | · | -0.3 | -0.4 | -0.5 | · | -0.2 | |
| P / Cash Flow | · | -1.4 | · | · | · | 3.2 | · | · | · | 5.1 | · | · | · | 134.0 | · | · | |
| EV / Revenue | 0.8 | 0.8 | · | 0.9 | 0.9 | 0.9 | · | 1.0 | 1.0 | 1.0 | · | 1.0 | 1.0 | 1.0 | · | 1.0 | |
| Earnings Yield | 55.7% | 117.0% | · | 75.4% | -43.8% | -136.3% | · | -49.6% | -22.3% | -26.9% | · | 62.8% | 49.8% | -0.82% | · | -68.4% |
Período mais recente à esquerda · valores nulos mostrados como ·
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Receita | $12.48B | $12.63B | $12.49B | $12.21B | $12.37B |
| Margem Operacional % | 11.9% | 4.3% | 7.7% | 6.7% | 11.3% |
| Lucro líquido | $509M | $-516M | $-133M | $46M | $230M |
| EPS Diluído | $3.77 | $-3.90 | $-1.02 | $0.35 | $1.76 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dívida / Patrimônio Líquido | -7.4 | -6.0 | -8.2 | -8.5 | -8.8 |
| Índice de liquidez corrente | 1.5 | 1.4 | 1.5 | 1.4 | 1.5 |
| Índice de Liquidez Seca | 1.1 | 1.0 | 1.1 | 1.0 | 1.1 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fluxo de caixa livre | $208M | $120M | $-257M | $-115M | $-600M |
Investidores institucionais (13F) 196 declarantes · $415.1M total · Em 30 de Setembro de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 31 (+9 vs trimestre anterior) | 24 (+4 vs trimestre anterior) | 69 (+6 vs trimestre anterior) | 54 (-9 vs trimestre anterior) | +7.0M |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| CastleKnight Management LP | $44.704.517 | 13.384.586 | 10,77% | Ações |
| Apollo Management Holdings, L.P. | $39.610.817 | 11.859.526 | 9,54% | Ações |
| BlackRock, Inc. | $36.507.995 | 10.930.538 | 8,79% | Ações |
| VANGUARD GROUP INC | $28.605.579 | 9.168.455 | 6,89% | Ações |
| Eversept Partners, LP | $26.267.680 | 7.864.575 | 6,33% | Ações |
| NOMURA HOLDINGS INC | $22.388.384 | 6.703.109 | 5,39% | Ações |
| VANGUARD CAPITAL MANAGEMENT LLC | $17.668.370 | 5.289.931 | 4,26% | Ações |
| WHITEBOX ADVISORS LLC | $12.467.362 | 3.732.743 | 3,00% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $10.582.352 | 3.167.702 | 2,55% | Ações |
| STATE STREET CORP | $10.226.622 | 3.061.863 | 2,46% | Ações |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $10.082.117 | 3.018.598 | 2,43% | Ações |
| Saba Capital Management, L.P. | $9.626.444 | 2.882.169 | 2,32% | Ações |
| Owl Creek Asset Management, L.P. | $8.452.277 | 2.530.622 | 2,04% | Ações |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $8.176.380 | 2.448.018 | 1,97% | Ações |
| DIMENSIONAL FUND ADVISORS LP | $7.854.253 | 2.351.460 | 1,89% | Ações |
| D. E. Shaw & Co., Inc. | $7.829.388 | 2.344.128 | 1,89% | Ações |
| AQR CAPITAL MANAGEMENT LLC | $7.651.362 | 2.290.827 | 1,84% | Ações |
| TWO SIGMA INVESTMENTS, LP | $7.365.822 | 2.205.336 | 1,77% | Ações |
| Diameter Capital Partners LP | $6.138.793 | 1.837.962 | 1,48% | Ações |
| BANK OF AMERICA CORP /DE/ | $5.903.847 | 1.767.619 | 1,42% | Ações |
| GOLDMAN SACHS GROUP INC | $5.868.073 | 1.756.908 | 1,41% | Ações |
| TWO SIGMA ADVISERS, LP | $5.816.476 | 1.864.255 | 1,40% | Ações |
| CARRONADE CAPITAL MANAGEMENT, LP | $5.230.000 | 1.565.847 | 1,26% | Ações |
| Allianz Asset Management GmbH | $5.167.919 | 1.547.281 | 1,24% | Ações |
| MORGAN STANLEY | $4.800.489 | 1.437.272 | 1,16% | Ações |
| NORTHERN TRUST CORP | $4.681.414 | 1.401.621 | 1,13% | Ações |
| Silver Rock Financial LP | $3.674.000 | 1.100.000 | 0,89% | Ações |
| CITADEL ADVISORS LLC | $3.475.360 | 1.040.527 | 0,84% | Ações |
| Assenagon Asset Management S.A. | $2.788.275 | 834.813 | 0,67% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $2.642.231 | 791.087 | 0,64% | Ações |
| Jefferies Financial Group Inc. | $2.481.286 | 742.900 | 0,60% | Ações |
| Alta Fundamental Advisers LLC | $2.161.411 | 647.129 | 0,52% | Ações |
| Bank of New York Mellon Corp | $2.122.084 | 635.354 | 0,51% | Ações |
| MARSHALL WACE, LLP | $1.906.575 | 570.831 | 0,46% | Ações |
| MILLENNIUM MANAGEMENT LLC | $1.701.580 | 509.455 | 0,41% | Ações |
| ExodusPoint Capital Management, LP | $1.664.603 | 498.384 | 0,40% | Ações |
| READYSTATE ASSET MANAGEMENT LP | $1.657.729 | 496.326 | 0,40% | Ações |
| WOLVERINE ASSET MANAGEMENT LLC | $1.339.674 | 401.100 | 0,32% | Opção de compra |
| Helix Partners Management LP | $1.336.000 | 400.000 | 0,32% | Ações |
| Susquehanna Portfolio Strategies, LLC | $1.280.940 | 383.515 | 0,31% | Ações |
| Voleon Capital Management LP | $1.247.032 | 373.363 | 0,30% | Ações |
| Invesco Ltd. | $1.076.599 | 322.335 | 0,26% | Ações |
| TUDOR INVESTMENT CORP ET AL | $999.388 | 299.218 | 0,24% | Ações |
| Pathstone Holdings, LLC | $895.621 | 268.150 | 0,22% | Ações |
| Prescott Group Capital Management, L.L.C. | $863.076 | 258.406 | 0,21% | Ações |
| UBS Group AG | $851.089 | 254.817 | 0,21% | Ações |
| MILLENNIUM MANAGEMENT LLC | $835.000 | 250.000 | 0,20% | Opção de venda |
| FEDERATED HERMES, INC. | $812.599 | 243.293 | 0,20% | Ações |
| LPL Financial LLC | $737.239 | 220.730 | 0,18% | Ações |
| IEQ CAPITAL, LLC | $657.963 | 196.995 | 0,16% | Ações |
Ativistas e proprietários de 5%+ 1 participação
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
| Declarante | Declarado | Participação | Status | Propósito | Declaração |
|---|---|---|---|---|---|
| Tianqiao Chen, Shanda Media Limited, Shanda Global Investment Limited, Shanda Global Capital Limited, Shanda Asset Management Holdings Limited ×10 declarações | 11 de Março de 2021 | · | Declaração inicial | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Executivos da empresa 56 insiders · 29 diretores · 23 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Kevin J Hammons | CEO | 1 de Março de 2026 A | 895.545 | 0 | 0 | $0 |
| Tim Hingtgen | CEO | 1 de Março de 2025 A | 1.388.781 | 0 | 0 | $0 |
| Jason K Johnson | EVP & CFO | 1 de Março de 2026 A | 268.439 | 0 | 0 | $0 |
| Thomas J Aaron | EVP and CFO | 7 de Dezembro de 2019 F | 241.515 | 0 | 0 | $0 |
| Larry W Cash | President and CFO | 1 de Março de 2017 A | 568.152 | 0 | 0 | $0 |
| Miguel S Benet | President and CMO | 1 de Março de 2025 D | 47.635 | 0 | 0 | $0 |
| Austen D Mason | Regional President | 1 de Março de 2025 A | 142.500 | 0 | 0 | $0 |
| Mark B Medley | Regional President | 1 de Março de 2025 A | 128.637 | 0 | 0 | $0 |
| Chad A Campbell | Regional President | 1 de Março de 2025 A | 136.815 | 0 | 0 | $0 |
| Charles J Cova | Regional President | 1 de Março de 2024 A | 58.701 | 0 | 0 | $0 |
| Lynn T Simon | President and CMO | 1 de Março de 2024 A | 482.657 | 0 | 0 | $0 |
| Beryl Ramsey | Division President | 1 de Março de 2019 A | 62.969 | 0 | 0 | $0 |
| Patton Paul Smith | Division President | 1 de Março de 2019 F | 119.017 | 0 | 0 | $0 |
| Iii John W Mcclellan | Division President | 1 de Março de 2017 A | 41.242 | 0 | 0 | $0 |
| Robert O Horrar | Division President | 1 de Março de 2017 A | 68.649 | 0 | 0 | $0 |
| Martin Bonick | Division President | 1 de Março de 2017 A | 100.458 | 0 | 0 | $0 |
| Michael T Portacci | Division President | 1 de Março de 2017 A | 110.156 | 0 | 0 | $0 |
| Thomas Daniel Miller | Division President | 1 de Março de 2016 A | 112.107 | 0 | 0 | $0 |
| David Lewis Miller | President and COO | 1 de Março de 2016 A | 440.840 | 0 | 0 | $0 |
| William S Hussey | Division President | 28 de Outubro de 2015 M | 121.568 | 0 | 0 | $0 |
| Martin Dewayne Smith | Division President | 3 de Junho de 2015 M | 94.111 | 0 | 0 | $0 |
| Gary D Newsome | Division President - Group Ops | 25 de Agosto de 2008 M | 118.286 | 0 | 0 | $0 |
| David V. Rice | EVP-Clinical Operations & CMO | 1 de Junho de 2026 A | 30.000 | 0 | 0 | $0 |
| Phillip A. Posey | SVP & CAO | 1 de Março de 2026 A | 51.736 | 0 | 0 | $0 |
| Justin D Pitt | Pres,Chief Legal&Admin Officer | 1 de Março de 2026 A | 287.750 | 0 | 0 | $0 |
| Kevin A Stockton | EVP, Operations & Development | 1 de Março de 2026 A | 208.290 | 0 | 0 | $0 |
| Rachel A Seifert | Executive VP and Secretary | 1 de Março de 2017 F | 243.065 | 0 | 0 | $0 |
| Mark T Buford | SVP/Chief Accounting Officer | 25 de Fevereiro de 2012 F | 78.379 | 0 | 0 | $0 |
| Martin G Schweinhart | Senior Vice President | 1 de Março de 2006 A | 40.354 | 0 | 0 | $0 |
| William Norris Jennings | Conselheiro | 25 de Agosto de 2026 S | 38.468 | 0 | 1 | $-118.400 |
| Ranga K Krishnan | Conselheiro | 30 de Junho de 2026 M | 170.023 | 0 | 0 | $0 |
| Fawn D Lopez | Conselheiro | 1 de Março de 2026 A | · | 0 | 0 | $0 |
| Ronald L Burgess JR | Conselheiro | 1 de Março de 2026 A | · | 0 | 0 | $0 |
| Susan W Brooks | Conselheiro | 1 de Março de 2026 A | 108.695 | 0 | 0 | $0 |
| Hubert James Williams | Conselheiro | 1 de Março de 2026 A | 211.863 | 0 | 0 | $0 |
| Joseph Arthur Hastings | Conselheiro | 1 de Março de 2026 A | 0 | 0 | 0 | $0 |
| Elizabeth T Hirsch | Conselheiro | 1 de Março de 2026 A | 162.059 | 0 | 0 | $0 |
| James S. Ely III | Conselheiro | 1 de Março de 2026 A | 412.876 | 0 | 0 | $0 |
| John A Fry | Conselheiro | 1 de Março de 2026 A | 268.966 | 0 | 0 | $0 |
| John A Clerico | Conselheiro | 1 de Março de 2026 A | 368.763 | 0 | 0 | $0 |
| Michael Dinkins | Conselheiro | 1 de Março de 2026 A | 225.882 | 0 | 0 | $0 |
| Wayne T Smith | Conselheiro | 1 de Março de 2026 A | 5.217.579 | 0 | 0 | $0 |
| Julia B North | Conselheiro | 1 de Março de 2021 A | 162.056 | 0 | 0 | $0 |
| Mitchell H Watson JR | Conselheiro | 16 de Maio de 2017 M | 22.594 | 0 | 0 | $0 |
| Harvey Klein MD | Conselheiro | 15 de Março de 2010 M | 10.383 | 0 | 0 | $0 |
| Dale F Frey | Conselheiro | 31 de Março de 2008 A | 20.000 | 0 | 0 | $0 |
| Thomas H Lister | Conselheiro | 21 de Setembro de 2004 S | 0 | 0 | 0 | $0 |
| Thodore Forstmann | Conselheiro | 21 de Setembro de 2004 S | 0 | 0 | 0 | $0 |
| Sandra Horbach | Conselheiro | 21 de Setembro de 2004 S | 0 | 0 | 0 | $0 |
| Robert J Dole | Conselheiro | 6 de Maio de 2004 S | 0 | 0 | 0 | $0 |
| FLC XXIX PARTNERSHIP LP | Detentor de 10% | 21 de Setembro de 2004 S | 0 | 0 | 0 | $0 |
| FLC XXX PARTNERSHIP LP | Detentor de 10% | 21 de Setembro de 2004 S | 0 | 0 | 0 | $0 |
| Winston Hutchins | Detentor de 10% | 21 de Setembro de 2004 S | 0 | 0 | 0 | $0 |
| FORSTMANN LITTLE & CO SUB DEBT & EQU MGMT BUYOUT PART VI LP | Detentor de 10% | 21 de Setembro de 2004 S | 0 | 0 | 0 | $0 |
| FORSTMANN LITTLE & CO EQUITY PARTNERSHIP V L P | Detentor de 10% | 21 de Setembro de 2004 S | 0 | 0 | 0 | $0 |
| Benjamin C Fordham | · | 1 de Março de 2021 A | 254.608 | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Participação em ETFs Detido por 25 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
| Fundo | Peso | Unidades | Em | Fonte |
|---|---|---|---|---|
| BSJR · Invesco Exchange-Traded Self-Indexe… | 2,85% | 24.817.000 | 2 de Outubro de 2026 | Diário |
| EBIT · Harbor ETF Trust | 0,45% | 19.210 NS | 31 de Julho de 2026 | N-PORT |
| IWC · iShares Trust | 0,09% | 443.690 SH | 11 de Setembro de 2026 | Diário |
| IHF · iShares Trust | 0,05% | 223.947 SH | 11 de Setembro de 2026 | Diário |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,03% | 113.109 SH | 19 de Agosto de 2026 | Diário |
| NEAR · iShares U.S. ETF Trust | 0,03% | 1.340.000 SH | 11 de Setembro de 2026 | Diário |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,02% | 221.871 SH | 2 de Outubro de 2026 | Diário |
| IWM · iShares Trust | 0,01% | 3.425.206 SH | 11 de Setembro de 2026 | Diário |
| RSSL · Global X Funds | 0,01% | 62.038 NS | 31 de Julho de 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 746.733 SH | 19 de Agosto de 2026 | Diário |
| VHT · VANGUARD WORLD FUND | 0,01% | 349.881 SH | 19 de Agosto de 2026 | Diário |
| DFAS · Dimensional ETF Trust | 0,01% | 289.348 NS | 31 de Julho de 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 202.789 NS | 31 de Julho de 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 33.838 NS | 31 de Julho de 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 203.848 SH | 11 de Setembro de 2026 | Diário |
| IWV · iShares Trust | 0,00% | 42.177 SH | 3 de Setembro de 2026 | Diário |
| DCOR · Dimensional ETF Trust | 0,00% | 6.184 NS | 31 de Julho de 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 31.135 NS | 31 de Julho de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 1.347.195 SH | 19 de Agosto de 2026 | Diário |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 3.813.888 SH | 19 de Agosto de 2026 | Diário |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 9.817 SH | 19 de Agosto de 2026 | Diário |
| DFSU · Dimensional ETF Trust | 0,00% | 24 NS | 31 de Julho de 2026 | N-PORT |
| VGHY · VANGUARD FIXED INCOME SECURITIES FU… | · | · | 15 de Julho de 2026 | Diário |
| VPLS · VANGUARD MALVERN FUNDS | · | · | 15 de Julho de 2026 | Diário |
| IWN · iShares Trust | · | 1.223.127 SH | 11 de Setembro de 2026 | Diário |
CYH Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
Preço-alvo de 12 meses
8 analistas · 2026-10-01Alvo médio $3.16 +16,0%
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
Base do ano fiscal, preços no fechamento do último ano fiscal de cada empresa.
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| CYH | $433M | 0.8 | -1.2% | 4.1% | -30.8% | · |
| SGRY | $2.00B | -25.3 | 6.2% | -2.4% | -4.5% | · |
| NUTX | $1.17B | 15.7 | 82.4% | 8.1% | 30.6% | 50.8% |
| ARDT | $1.26B | 9.2 | 6.0% | 2.1% | 11.2% | · |
| USPH | · | 55.0 | 16.3% | 5.1% | 8.2% | 19.2% |
| STLN | · | · | · | · | · | · |
| JYNT | $123M | 45.9 | 5.2% | 5.3% | 16.3% | · |
| HCA | $104.86B | 16.5 | 7.1% | 9.0% | -159.1% | · |
Últimas notícias Notícias recentes mencionando esta empresa
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
Escolha as métricas que importam para si — clique no + ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.